Pelthos Therapeutics to Participate in Upcoming September Investor Conferences
Pelthos Therapeutics Inc. (PTHS)
Company Research
Source: GlobeNewswire
DURHAM, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today announced that Scott Plesha, CEO, and Frank Knuettel II, CFO, will participate in the upcoming September conferences: H.C. Wainwright 27th Annual Global Investment Conference and the Investor Summit Group Q3 Virtual Conference. Investor Conference Details: H.C. Wainwright 27th Annual Global Investment ConferenceLocation: Lotte New York Palace Hotel, New York CityConference Dates: September 8-10, 2025Presentation Date: September 10, 2025 at 10:30 A.M. ETOne on one meeting availability: September 10, 2025 Institutional investors interested in scheduling an in-person one-on-one meeting should contact their institutional sales rep or register for the conference via this LINK. A webcast of the presentation will be available on the Ev
Show less
Read more
Impact Snapshot
Event Time:
PTHS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTHS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTHS alerts
High impacting Pelthos Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
PTHS
News
- Pelthos Therapeutics Signs Major Pharmacy Benefit Manager Agreement Expanding Patient Access to ZELSUVMI™ (berdazimer) Topical Gel, 10.3%GlobeNewswire
- Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial ResultsGlobeNewswire
- Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes FinancingGlobeNewswire
PTHS
Earnings
- 11/13/25 - Miss
PTHS
Sec Filings
- 12/1/25 - Form ARS
- 11/26/25 - Form 4
- 11/25/25 - Form DEF
- PTHS's page on the SEC website